首页> 外文期刊>Journal of the American Medical Directors Association >Management of Dyspnea and Anxiety in Chronic Obstructive Pulmonary Disease: A Critical Review
【24h】

Management of Dyspnea and Anxiety in Chronic Obstructive Pulmonary Disease: A Critical Review

机译:慢性阻塞性肺病中呼吸困难和焦虑的管理:批判性评论

获取原文
获取外文期刊封面目录资料

摘要

Abstract Background Anxiety and dyspnea, 2 major symptoms in patients with chronic obstructive pulmonary disease (COPD), are associated with high morbidity and mortality. Thus, critically evaluating and synthesizing the existing literature employing pulmonary rehabilitation (PR) and other behavioral therapies in the treatment of anxiety and dyspnea in patients with COPD may help clinicians determine the most efficacious potential treatments. We aim to examine the efficacy of PR and behavioral therapy [eg, cognitive behavioral therapy (CBT) and counseling] and other adjunct modalities used in patients with COPD. Methods We extracted relevant studies searching the published literature using an electronic database CINAHL, Medline, PubMed, Science Direct, and the Web of Science was conducted (spanning January 1, 2006 to November 15, 2016). Studies were included if they conducted PR and behavioral therapy (CBT, self-management, yoga) to treat anxiety and/or dyspnea in patients with COPD with or without randomized controlled trial. Results The 47 studies selected included 4595 participants (PR??756 and behavioral therapy??39), ranging in age from 58 to 75爕ears. The total number of participants receiving a treatment was 3928, and 667 participants served in control groups. In the majority of studies, PR and CBT are effective in the treatment of anxiety and dyspnea in the short term, but the long-term benefit is limited. In addition, self-management, yoga therapy, and CBT plus PR were beneficial. Conclusions PR and CBT reduced both anxiety and dyspnea symptoms in patients with COPD in the short term. However, maintenance programs and the long-term benefits of PR and CBT remain inconclusive. Generally, the studies were relatively small and uncontrolled. Thus, prospective and randomized controlled trials with larger sample sizes are needed.
机译:摘要背景焦虑和呼吸困难,2患者慢性阻塞性肺病(COPD)的主要症状,与高发病率和死亡率有关。因此,重视和合成使用肺康复(PR)和其他行为疗法在患有COPD患者的焦虑和呼吸困难的其他行为疗法中的现有文献可能有助于临床医生确定最有效的潜在治疗方法。我们的目标是检查PR和行为治疗的疗效[例如,认知行为治疗(CBT)和咨询]以及COPD患者使用的其他辅助方式。方法采用电子数据库,Medline,PubMed,Science Direct和Science的网站,提取了搜查出版文献的相关研究,并进行了科学网络(跨越2006年1月1日至2016年11月15日)。如果他们进行了PR和行为治疗(CBT,自我管理,瑜伽),则包括研究,以治疗COPD患者的焦虑和/或呼吸困难,或没有随机对照试验。结果选择47项研究包括4595名参与者(Pr ?? 756和行为治疗?? 39),从58到75岁的耳朵范围内。接受治疗的参与者总数为3928,对照组服务667名参与者。在大多数研究中,PR和CBT在短期内有效地治疗焦虑和呼吸困难,但长期利益有限。此外,自我管理,瑜伽疗法和CBT Plus PR有益。结论PR和CBT在短期内减少了COPD患者的焦虑和呼吸困难症状。但是,PR和CBT的维护计划和长期福利仍然不确定。通常,研究相对较小和不受控制。因此,需要具有较大样本尺寸的前瞻性和随机对照试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号